Entropy Technologies’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.89M Buy
+3,487
New +$1.8M 0.06% 419
2026
Q1
– Sell
-1,940
Closed -$945K – 1176
2025
Q4
$945K Buy
1,940
+740
+62% +$345K 0.05% 403
2025
Q3
$503K Buy
+1,200
New +$404K 0.04% 516
2024
Q4
– Sell
-1,683
Closed -$603K – 1011
2024
Q3
$603K Sell
1,683
-1,297
-44% -$438K 0.06% 388
2024
Q2
$949K Buy
+2,980
New +$789K 0.1% 250

Other funds holding UTHR

Entropy Technologies's UTHR Position: Q3 2026 in Review

Entropy Technologies opened a new position in United Therapeutics (UTHR) in Q3 2026: 3,487 shares worth $1.89M. The stake represents 0.06% of the portfolio and ranks #419 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in UTHR as recently as Q4 2025.

Entropy Technologies first reported a position in UTHR in Q2 2024 and has held it in 5 quarters since. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Entropy Technologies held 3,487 shares of United Therapeutics worth $1.89M as of Q3 2026.
  • United Therapeutics was a new Entropy Technologies position in Q3 2026.
  • United Therapeutics made up 0.06% of Entropy Technologies's portfolio in Q3 2026, its #419 holding.
  • Entropy Technologies first reported a position in United Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.